🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

FTSE 100 suffers biggest weekly fall in 10 months

Published 04/11/2016, 17:16
© Reuters. A red London bus passes the Stock Exchange in London
UK100
-
HIK
-
AAL
-
BHPB
-
RRS
-
FLTRF
-
FRES
-
FTMC
-
FTNMX551030
-

By Alistair Smout and Atul Prakash

LONDON (Reuters) - Britain's top share index hit a seven-week low on Friday and registered its biggest weekly loss in 10 months as drugmakers came under pressure from political scrutiny in the United States ahead of its Nov. 8 elections.

The blue-chip FTSE 100 (FTSE) index closed 1.4 percent weaker after falling to its lowest level since mid-September. The benchmark index fell more than 4 percent for the week, the biggest weekly drop since January.

Miners also slumped after a fall in some metals prices. The UK mining index (FTNMX1770) tumbled 2.3 percent, dragged down by a 1.8 to 4.6 percent drop in BHP Billiton (L:BLT), Anglo American (L:AAL), Randgold Resources (L:RRS) and Fresnillo (L:FRES).

The mid-cap FTSE 250 (FTMC) ended 1.8 percent lower. The domestically-focused index had rallied on Thursday following a court ruling that the British government had to consult parliament on triggering Brexit. However, traders said that growing uncertainties were hurting the market.

They said that next Tuesday's U.S. presidential election was weighing on sentiment. Republican Donald Trump has closed the gap on Democrat Hillary Clinton in the polls in recent days, and there is uncertainty in the market over what a Trump presidency would do to the economy.

Two U.S. lawmakers called on Thursday for an investigation into whether major pharmaceutical firms colluded to set prices for insulin and other diabetes drugs.

Drugmaker Hikma Pharma (L:HIK), down 6.8 percent, was the worst performer in the FTSE 100 index, with HSBC highlighting the risk that the company could be dragged into the inquiry.

"It's uncertainty around the election which is knocking sentiment at the moment, but pharmaceuticals will likely feel the heat whichever way it goes," said Jasper Lawler, market analyst at CMC Markets. "Clinton will probably be harsher on pricing on the sector, but Trump could be quite interventionist as well and take on these populist causes."

Friday's fall was broad-based, with only six FTSE 100 stocks staying in positive territory.

Paddy Power Betfair (L:PPB) was the stand-out gainer, rising 4.1 percent as it benefited from foreign exchange effects following a fall in sterling after the Brexit referendum, and better synergies from its recent merger.

The merger between Paddy Power and Betfair was completed in February this year.

© Reuters. A red London bus passes the Stock Exchange in London

"It seems like the drop in the pound came at just the right time, as the merger is starting to bear fruit, as they're using their higher market share to push both services," CMC's Lawler said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.